The central bank is not normally in the business of easing into an economy that is showing few signs of a recession, generally holding fire until more pronounced signs of a...The Fedread more
His case for gold comes as central banks get more aggressive with policies that devalue currencies and are about to cause a "paradigm shift" in investing.Marketsread more
CSX said it expects revenue to fall as much as 2% in 2019, well below a previous forecast of an increase of 1% to 2%.Marketsread more
Challenging conditions in the U.S. housing market, along with tighter currency controls by the Chinese government, cause a stunning drop in foreign demand for American homes.Real Estateread more
The growth in net interest income, a main engine of the industry's profit, looks to slow to a halt in the back half of this year.Banksread more
These are the stocks posting the largest moves midday.Market Insiderread more
Here's how Amazon sells ads, and why it has a natural edge over Google and Facebook in some areas.Technologyread more
Netflix reports earnings Wednesday as it loses licensed shows to rivals launching their own streaming services.Technologyread more
Federal Judge William Pauley wrote in a court filing made public Wednesday that materials related to Cohen's campaign-finance probe should be unsealed — and denied a request...Politicsread more
The "'Cadillac tax," set to go into effect in 2022, is unpopular with both Republicans and Democrats, who say it punishes the middle class.Health and Scienceread more
Facebook's head of Calibra David Marcus is grilled during a House Financial Services Committee hearing over the company's digital currency plans.Technologyread more
Check out the companies making headlines after the bell:
PG&E shares rose as much as 2 percent during the extended session Monday after the stock plummeted over 17 percent during the trading day. State regulators are investigating whether the utilities company's facilities were involved in the beginning of the California wildfires that have killed 31 people.
Eventbrite shares declined over 8 percent after hours as the company missed earnings expectations. The company reported a loss of $1.24 a share, while analysts predicted a loss of 47 cents per share. However, it beat revenue expectations, reporting $73.6 million. Analysts had expected $71.7 million. The company gave strong revenue guidance for the fourth quarter.
Sage Therapeutics dropped more than 2 percent during the extended session. The drop came after Leerink, an investment bank focused on health care, described the company as its least favorite in the biopharmaceutical space, giving the stock a price target of $80 -- well below Monday's closing price of $121.44. Leerink said Sage's drug for postpartum depression, Zulresso, is a niche product that will have low peak sales and a slow ramp after approval.